CAS: 2066488-39-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | (S)-C33 REF: IN-DA01ENINCAS: 2066488-39-7 | 98% | A consultar | Mar 10 Dic 24 |
 | PDE9-IN-(S)-C33 REF: 3D-RHD48839CAS: 2066488-39-7 | Min. 95% | A consultar | Mar 21 Ene 25 |
 | PDE9-IN-(S)-C33 REF: TM-T28352CAS: 2066488-39-7 | 98.75% | 51,00 €~536,00 € | Mar 11 Feb 25 |
Ref: IN-DA01ENIN
| 10mg | 170,00 € | ||
| 25mg | 241,00 € | ||
| 50mg | 543,00 € | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
PDE9-IN-(S)-C33
CAS:2066488-39-7
PDE9-IN-(S)-C33 is a phosphodiesterase inhibitor that is used in the treatment of heart diseases such …
Fórmula:
C18H20ClN5O
Pureza:
Min. 95%
Peso molecular:
357.8 g/mol
Ref: 3D-RHD48839
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
PDE9-IN-(S)-C33
CAS:2066488-39-7
PDE9-IN-(S)-C33: potent PDE9 inhibitor with 11 nM IC50, for CNS diseases and diabetes study.
Fórmula:
C18H20ClN5O
Pureza:
98.75%
Forma y color:
Solid
Peso molecular:
357.84
Ref: TM-T28352
| 1mg | 60,00 € | ||
| 5mg | 109,00 € | ||
| 10mg | 155,00 € | ||
| 25mg | 243,00 € | ||
| 50mg | 360,00 € | ||
| 100mg | 536,00 € | ||
| 1mL*10mM (DMSO) | 123,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Febrero de 2025
